Top compounds associated with response to FAM13C


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA CUDC-101 GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA BX-912 GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.17 6e-06
Download CSV